ADALAT CC

Adalat Cc Adverse Events Reported to the FDA Over Time

How are Adalat Cc adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Adalat Cc, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Adalat Cc is flagged as the suspect drug causing the adverse event.

Most Common Adalat Cc Adverse Events Reported to the FDA

What are the most common Adalat Cc adverse events reported to the FDA?

Oedema Peripheral	16 (2.02%)
Hypertension	14 (1.77%)
Pyrexia	13 (1.64%)
Hypotension	11 (1.39%)
Dyspnoea	10 (1.26%)
Back Pain	9 (1.14%)
Renal Impairment	9 (1.14%)
Asthma	8 (1.01%)
Hepatic Function Abnormal	8 (1.01%)
Medication Error	8 (1.01%)
Anaemia	7 (.88%)
	Show More
Blood Pressure Increased	7 (.88%)
Cutaneous Vasculitis	7 (.88%)
Dizziness	7 (.88%)
Drug Eruption	7 (.88%)
Interstitial Lung Disease	7 (.88%)
Psoriasis	7 (.88%)
Rash Pruritic	7 (.88%)
Altered State Of Consciousness	6 (.76%)
Blood Pressure Inadequately Control...	6 (.76%)
Cardiac Failure Chronic	6 (.76%)
Diabetes Mellitus Inadequate Contro...	6 (.76%)
Disseminated Intravascular Coagulat...	6 (.76%)
Liver Disorder	6 (.76%)
Pulmonary Congestion	6 (.76%)
Weight Increased	6 (.76%)
Angina Pectoris	5 (.63%)
Ascites	5 (.63%)
Blood Pressure Decreased	5 (.63%)
Cardiac Arrest	5 (.63%)
Cerebral Infarction	5 (.63%)
Chest Discomfort	5 (.63%)
Chest Pain	5 (.63%)
Epstein-barr Virus Infection	5 (.63%)
Flushing	5 (.63%)
Heart Rate Increased	5 (.63%)
Malaise	5 (.63%)
Multi-organ Failure	5 (.63%)
Pain	5 (.63%)
Rash	5 (.63%)
Sepsis	5 (.63%)
Tachycardia	5 (.63%)
White Blood Cell Count Decreased	5 (.63%)
Abdominal Distension	4 (.51%)
Adverse Drug Reaction	4 (.51%)
Blindness	4 (.51%)
Bradycardia	4 (.51%)
Caesarean Section	4 (.51%)
Cardio-respiratory Arrest	4 (.51%)
Cellulitis	4 (.51%)
Condition Aggravated	4 (.51%)
Erythema	4 (.51%)
Eye Haemorrhage	4 (.51%)
Feeling Hot	4 (.51%)
Haematemesis	4 (.51%)
Insomnia	4 (.51%)
Lymphoma	4 (.51%)
Neutropenia	4 (.51%)
Nocturia	4 (.51%)
Oedema	4 (.51%)
Orthostatic Hypotension	4 (.51%)
Platelet Count Decreased	4 (.51%)
Pleural Effusion	4 (.51%)
Pollakiuria	4 (.51%)
Prostatitis	4 (.51%)
Tinnitus	4 (.51%)
Toxic Skin Eruption	4 (.51%)
Vision Blurred	4 (.51%)
Abnormal Behaviour	3 (.38%)
Adverse Event	3 (.38%)
Agranulocytosis	3 (.38%)
Arthralgia	3 (.38%)
Asthenia	3 (.38%)
Blood Creatinine Increased	3 (.38%)
Blood Pressure Abnormal	3 (.38%)
Blood Urea Increased	3 (.38%)
Cardiac Failure	3 (.38%)
Cardiogenic Shock	3 (.38%)
Cleft Lip	3 (.38%)
Cleft Palate	3 (.38%)
Clonic Convulsion	3 (.38%)
Drug Ineffective	3 (.38%)
Dyskinesia	3 (.38%)
Electrocardiogram St Segment Depres...	3 (.38%)
Fall	3 (.38%)
Fluid Retention	3 (.38%)
Foetal Disorder	3 (.38%)
Gingival Swelling	3 (.38%)
Medication Residue	3 (.38%)
Mental Impairment	3 (.38%)
Muscle Spasms	3 (.38%)
No Adverse Event	3 (.38%)
Palpitations	3 (.38%)
Protein Urine Present	3 (.38%)
Pruritus	3 (.38%)
Sensory Integrative Dysfunction	3 (.38%)
Shock	3 (.38%)
Skin Exfoliation	3 (.38%)
Transient Ischaemic Attack	3 (.38%)
Tremor	3 (.38%)
Umbilical Cord Vascular Disorder	3 (.38%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Adalat Cc, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Adalat Cc is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Adalat Cc

What are the most common Adalat Cc adverse events reported to the FDA?

Epidermal And Dermal Conditions	44 (5.56%)
Cardiac Arrhythmias	32 (4.05%)
Cardiac And Vascular Investigations	31 (3.92%)
Neurological	27 (3.41%)
Respiratory	26 (3.29%)
Decreased And Nonspecific Blood Pre...	24 (3.03%)
Medication Errors	20 (2.53%)
Hepatic And Hepatobiliary	19 (2.4%)
Lower Respiratory Tract Disorders	17 (2.15%)
Renal Disorders	16 (2.02%)
Renal And Urinary Tract Investigati...	15 (1.9%)
	Show More
Therapeutic And Nontherapeutic Effe...	15 (1.9%)
Vascular Hypertensive	15 (1.9%)
Heart Failures	14 (1.77%)
Body Temperature Conditions	13 (1.64%)
Gastrointestinal Signs	13 (1.64%)
Anemias Nonhemolytic And Marrow Dep...	12 (1.52%)
Glucose Metabolism Disorders	12 (1.52%)
Hematology Investigations	12 (1.52%)
Musculoskeletal And Connective Tiss...	12 (1.52%)
Urinary Tract Signs	12 (1.52%)
Gastrointestinal Hemorrhages	11 (1.39%)
Central Nervous System Vascular	10 (1.26%)
Coronary Artery	10 (1.26%)
Dental And Gingival Conditions	10 (1.26%)
Infections - Pathogen Unspecified	10 (1.26%)
Electrolyte And Fluid Balance Condi...	9 (1.14%)
Bronchial Disorders	8 (1.01%)
Physical Examination Topics	8 (1.01%)
Vision	8 (1.01%)
White Blood Cell	8 (1.01%)
Coagulopathies And Bleeding Diathes...	7 (.88%)
Hepatobiliary	7 (.88%)
Skin Vascular Abnormalities	7 (.88%)
Fetal Complications	6 (.76%)
Joint	6 (.76%)
Movement Disorders	6 (.76%)
Muscle	6 (.76%)
Cardiac Disorder Signs	5 (.63%)
Gastrointestinal Motility And Defec...	5 (.63%)
Nephropathies	5 (.63%)
Oral Soft Tissue Conditions	5 (.63%)
Peritoneal And Retroperitoneal Cond...	5 (.63%)
Vascular	5 (.63%)
Viral Infectious	5 (.63%)
Appetite And General Nutritional	4 (.51%)
Bacterial Infectious	4 (.51%)
Enzyme	4 (.51%)
Injuries	4 (.51%)
Inner Ear And Viiith Cranial Nerve	4 (.51%)
Lymphomas	4 (.51%)
Male Reproductive Tract Infections ...	4 (.51%)
Myocardial	4 (.51%)
Neonatal And Perinatal Conditions	4 (.51%)
Obstetric And Gynecological Therape...	4 (.51%)
Ocular Hemorrhages And Vascular	4 (.51%)
Pleural	4 (.51%)
Seizures	4 (.51%)
Skin Appendage Conditions	4 (.51%)
Sleep Disorders	4 (.51%)
Bone And Joint Injuries	3 (.38%)
Chemical Injury And Poisoning	3 (.38%)
Gastrointestinal Tract Disorders Co...	3 (.38%)
Gastrointestinal Vascular Condition...	3 (.38%)
Lifestyle Issues	3 (.38%)
Mental Impairment	3 (.38%)
Musculoskeletal And Connective Tiss...	3 (.38%)
Product Quality Issues	3 (.38%)
Protein And Chemistry Analyses	3 (.38%)
Psychiatric And Behavioural Symptom...	3 (.38%)
Upper Respiratory Tract Disorders	3 (.38%)
Abdominal Hernias And Other Abdomin...	2 (.25%)
Abortions And Stillbirth	2 (.25%)
Anxiety Disorders	2 (.25%)
Arteriosclerosis, Stenosis, Vascula...	2 (.25%)
Depressed Mood Disorders	2 (.25%)
Encephalopathies	2 (.25%)
Fatal Outcomes	2 (.25%)
Gastrointestinal Neoplasms Benign	2 (.25%)
Headaches	2 (.25%)
Hematological And Lymphoid Tissue T...	2 (.25%)
Hepatobiliary Therapeutic Procedure...	2 (.25%)
Injuries By Physical Agents	2 (.25%)
Malabsorption Conditions	2 (.25%)
Placental, Amniotic And Cavity Diso...	2 (.25%)
Platelet	2 (.25%)
Toxicology And Therapeutic Drug Mon...	2 (.25%)
Benign Neoplasms Gastrointestinal	1 (.13%)
Cardiac Valve	1 (.13%)
Deliria	1 (.13%)
Exocrine Pancreas Conditions	1 (.13%)
Family Issues	1 (.13%)
Gastrointestinal Inflammatory Condi...	1 (.13%)
Gastrointestinal Stenosis And Obstr...	1 (.13%)
Gastrointestinal Ulceration And Per...	1 (.13%)
Hearing	1 (.13%)
Leukemias	1 (.13%)
Lymphomas Non-hodgkins B-cell	1 (.13%)
Metabolic, Nutritional And Blood Ga...	1 (.13%)
Microbiology And Serology	1 (.13%)
Pulmonary Vascular	1 (.13%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Adalat Cc, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Adalat Cc is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.